Clinical trial
Maintenance Chemotherapy in Metastatic Breast Cancer
NCT00289263 · MANTA 1 Study Italian Collaborative Group, Other · Unknown status
Key facts
| NCT number | NCT00289263 |
|---|---|
| Title | Maintenance Chemotherapy in Metastatic Breast Cancer |
| Official title | Maintenance Paclitaxel Vs Control After Anthracycline/Paclitaxel Combined First-Line Chemotherapy in Metastatic Breast Cancer |
| Lead sponsor | MANTA 1 Study Italian Collaborative Group, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Paclitaxel |
| Enrollment | 524 |
| Start date | Apr 1, 1998 |
| Completion | Oct 1, 2003 |
| First posted | Feb 9, 2006 |
| Last update posted | Feb 9, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: